These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

870 related articles for article (PubMed ID: 9166466)

  • 41. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy.
    Gunel N; Akcali Z; Coskun U; Akyol G; Yamac D; Yenidünya S
    Pathol Res Pract; 2002; 198(1):7-12. PubMed ID: 11866215
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rho GDP dissociation inhibitor alpha expression correlates with the outcome of CMF treatment in invasive ductal breast cancer.
    Ronneburg H; Span PN; Kantelhardt E; Dittmer A; Schunke D; Holzhausen HJ; Sweep FC; Dittmer J
    Int J Oncol; 2010 Feb; 36(2):379-86. PubMed ID: 20043072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical features and prognostic factors of small breast cancer with multiple axillary lymph node metastasis].
    Liao YQ; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):615-8. PubMed ID: 18210884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.
    Vartanian RK; Weidner N
    Am J Pathol; 1994 Jun; 144(6):1188-94. PubMed ID: 7515558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast.
    Morphopoulos G; Pearson M; Ryder WD; Howell A; Harris M
    J Pathol; 1996 Sep; 180(1):44-9. PubMed ID: 8943814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
    Gilje B; Nordgård O; Tjensvoll K; Janssen EA; Søiland H; Smaaland R; Baak JP
    Breast Cancer Res Treat; 2011 Jul; 128(1):137-46. PubMed ID: 21476002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of chemotherapy for node-negative breast cancer.
    Cooper MR
    Cancer; 1991 Mar; 67(6 Suppl):1744-7. PubMed ID: 2001570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of lymph node metastasis in the systemic dissemination of breast cancer.
    Nathanson SD; Kwon D; Kapke A; Alford SH; Chitale D
    Ann Surg Oncol; 2009 Dec; 16(12):3396-405. PubMed ID: 19657697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays.
    Albain KS; Paik S; van't Veer L
    Breast; 2009 Oct; 18 Suppl 3():S141-5. PubMed ID: 19914534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen.
    Meattini I; Livi L; Saieva C; Franceschini D; Scotti V; Mangoni M; Loi M; Di Brina L; Zei G; Bonomo P; Greto D; Gelain E; Nori J; Sanchez LJ; Orzalesi L; Bianchi S; Biti G
    Clin Breast Cancer; 2013 Aug; 13(4):247-53. PubMed ID: 23684167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer.
    Criscitiello C; Disalvatore D; De Laurentiis M; Gelao L; Fumagalli L; Locatelli M; Bagnardi V; Rotmensz N; Esposito A; Minchella I; De Placido S; Santangelo M; Viale G; Goldhirsch A; Curigliano G
    Breast; 2014 Feb; 23(1):69-75. PubMed ID: 24314620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Significance of tumor angiogenesis as an independent prognostic factor in axillary node-negative breast cancer].
    Inada K; Toi M; Hoshina S; Hayashi K; Tominaga T
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():59-65. PubMed ID: 7538284
    [TBL] [Abstract][Full Text] [Related]  

  • 56. p95HER-2 predicts worse outcome in patients with HER-2-positive breast cancer.
    Sáez R; Molina MA; Ramsey EE; Rojo F; Keenan EJ; Albanell J; Lluch A; García-Conde J; Baselga J; Clinton GM
    Clin Cancer Res; 2006 Jan; 12(2):424-31. PubMed ID: 16428482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adjuvant systemic therapy and survival after breast cancer.
    Olivotto IA; Bajdik CD; Plenderleith IH; Coppin CM; Gelmon KA; Jackson SM; Ragaz J; Wilson KS; Worth A
    N Engl J Med; 1994 Mar; 330(12):805-10. PubMed ID: 8114832
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment.
    Søreide JA; Lea OA; Varhaug JE; Skarstein A; Kvinnsland S
    Eur J Surg Oncol; 1992 Apr; 18(2):112-8. PubMed ID: 1582503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjuvant systemic treatment of resectable breast cancer: eleven years results of a monoinstitutional chemo-hormone-immunotherapy trial.
    Rosso R; Boccardo F; Brema F; Sertoli MR; Amoroso D; Bertelli G; Pronzato P
    Anticancer Res; 1989; 9(4):1153-6. PubMed ID: 2817796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. E2F1 expression predicts outcome in Korean women who undergo surgery for breast carcinoma.
    Kwon MJ; Nam ES; Cho SJ; Park HR; Shin HS; Park JH; Park CH; Lee WJ
    Ann Surg Oncol; 2010 Feb; 17(2):564-71. PubMed ID: 19841979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.